Nvidia is pushing AI as the key to fixing the broken, decade-long drug discovery process. The vision hinges on using transformer models, similar to those in ChatGPT, to understand human biology at the DNA and protein level.
Align Technology is strengthening its footprint in South Africa with a new country manager and expanded team. The Nasdaq-listed company sees major growth potential in the region’s digital dentistry market. This move comes as the global digital dentistry market is projected to reach $17.7 billion by
China’s healthcare system faces a stark divide between world-class urban hospitals and understaffed rural clinics. AI medical chatbots are now being deployed nationwide to bridge this gap. What China learns from this massive experiment could transform healthcare delivery globally.
Researchers at the Institute of Science Tokyo created an innovative enzyme switch called Switchbody that activates only when bound to its target antigen. The technology uses a trap-and-release mechanism that could revolutionize diagnostics and therapeutics. The team published their findings in Advan
Multi-agent AI systems are transforming medical research and diagnosis. Google DeepMind’s approach uses teams of AI agents that collaborate for weeks to solve complex problems that previously took human researchers years.
A new AI-powered smartphone application analyzes facial micro-expressions to assess pain levels objectively. The technology emerges as healthcare professionals grapple with the inherent subjectivity of traditional pain scales.
Pain assessment has long presented a significant challenge for medical professionals, with patients often struggling to quantify their discomfort using traditional numerical scales. According to reports, the subjective nature of pain means individuals experience and describe discomfort differently based on their personal history, emotional state, and expectations. Sources indicate that even the same injury can produce dramatically different pain reports from different patients.
Breakthrough Research Identifies UNC13A-Related Neurodevelopmental Syndrome Groundbreaking research published in Nature Genetics has uncovered a previously unrecognized neurodevelopmental syndrome caused…
Robotic Surgery Demand Fuels Impressive Quarterly Performance Intuitive Surgical, the pioneer in robotic-assisted minimally invasive surgery, delivered outstanding third-quarter results…
A groundbreaking blood test has demonstrated remarkable success in detecting over 50 cancer types in major clinical trials. The test identified more than half of cancers at early stages when they’re most treatable, according to study results presented at a leading medical conference.
A revolutionary blood test designed to detect more than 50 types of cancer has delivered highly promising results in one of the largest interventional screening trials conducted to date, according to reports presented at the European Society for Medical Oncology Congress 2025 in Berlin. The PATHFINDER 2 study of the Galleri multi-cancer early detection (MCED) test reportedly showed a more than seven-fold increase in cancer detection rates when used alongside standard recommended screenings.
Decoding the Chromatin Loop-Cancer Stem Cell Connection Groundbreaking research published in Nature Communications has revealed a previously unknown mechanism through…
